174 Participants Needed

Risdiplam for Spinal Muscular Atrophy

(Jewelfish Trial)

Recruiting at 38 trial locations
Age: < 65
Sex: Any
Trial Phase: Phase 2
Sponsor: Hoffmann-La Roche
Must be taking: Nusinersen, Olesoxime, AVXS-101
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 9 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a multi-center, exploratory, non-comparative, and open-label study to investigate the safety, tolerability, PK, and PK/PD relationship of risdiplam in adults, children and infants with Spinal Muscular Atrophy (SMA) previously enrolled in Study BP29420 (Moonfish) with the splicing modifier RO6885247 or previously treated with nusinersen, olesoxime or AVXS-101.

Who Is on the Research Team?

CT

Clinical Trials

Principal Investigator

Hoffmann-La Roche

Are You a Good Fit for This Trial?

This trial is for adults, children, and infants with Spinal Muscular Atrophy who have been part of a previous study or treated with specific drugs. Women must not be pregnant and agree to contraception; men also need to use birth control. Participants should be well enough in the investigator's opinion, and young children may need feeding tubes or ventilation as recommended.

Inclusion Criteria

I have previously participated in the Moonfish study or have been treated with specific drugs for my condition.
Adequately recovered from any acute illness at the time of screening and considered well enough to participate in the opinion of the Investigator For women of childbearing potential: negative blood pregnancy test at screening, agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive measures, and agreement to refrain from donating eggs for at least 28 days after the final dose of study drug
I agree to not have sex or use birth control and not donate sperm.
See 7 more

Exclusion Criteria

I have a history of cancer that is not considered cured.
I have previously used chloroquine, hydroxychloroquine, retigabin, vigabatrin, or thioridazine.
I have had an eye disease in the last year.
See 17 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive multiple doses of risdiplam orally once daily

24 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Open-label extension

Participants may opt into continuation of treatment long-term

3 years

What Are the Treatments Tested in This Trial?

Interventions

  • Risdiplam
Trial Overview The trial tests Risdiplam's safety, tolerability, how it moves through and affects the body (PK/PD) in those with SMA previously enrolled in a related study or treated with certain other medications. It's an exploratory open-label study without comparison groups.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: RisdiplamExperimental Treatment1 Intervention

Risdiplam is already approved in United States, European Union, Brazil, China for the following indications:

🇺🇸
Approved in United States as Evrysdi for:
🇪🇺
Approved in European Union as Evrysdi for:
🇧🇷
Approved in Brazil as Evrysdi for:
🇨🇳
Approved in China as Evrysdi for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Hoffmann-La Roche

Lead Sponsor

Trials
2,482
Recruited
1,107,000+
Headquarters
Basel, Switzerland
Known For
Precision medicine
Top Products
Avastin, Herceptin, Rituxan, Accu-Chek
Dr. Levi Garraway profile image

Dr. Levi Garraway

Hoffmann-La Roche

Chief Medical Officer since 2019

MD from the University of Basel

Dr. Thomas Schinecker profile image

Dr. Thomas Schinecker

Hoffmann-La Roche

Chief Executive Officer since 2023

PhD in Molecular Biology from New York University

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security